Project 1: Thymic Stromal Lymphopoietin Signaling in Germinal Centers, Plasma Cells, and Memory B cells.
We previously identified the alarmin cytokine, Thymic Stromal Lymphopoietin (TSLP), as a crucial regulator of germinal center responses in mice (PMID: 36608149), however several new studies in the Domeier laboratory will determine how this cytokine impacts the maintenance and function of memory B cells and plasma cells. A separate project will also use a novel tonsil organoid culture system to determine how TSLP-targeted therapeutics impact human germinal center responses.
Project 2: Germinal Center-mediated photosensitivity in autoimmunity.
We previously observed disrupted GC responses in a humanized mouse model of IPEX syndrome (PMID: 35749515), resulting in high circulating concentrations of skin-specific IgE autoantibodies. These mice also exhibit exaggerated inflammatory responses after sunburn (photosensitivity), mimicking similar disease phenotypes in several skin-related autoimmune diseases. Using this model, we will investigate the altered germinal center pathways in these mice to determine how skin-reactive IgE is generated in patients with autoimmune photosensitivity.
Project 3: Engineering Tonsil Organoids.
Several groups are now working with an innovative organoid culture system (called tonsil organoids), that allow for in-depth studies of human GC responses in vitro. Several projects are planned to optimize tonsil organoid performance through supplementation of cytokines and/or growth factors. Overall, the goal of this study will be to develop a high-throughput method for testing vaccine candidates and/or identifying novel therapeutic targets to selectively modify germinal center responses in vivo.